C De Wolf-Peeters
Overview
Explore the profile of C De Wolf-Peeters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
252
Citations
3729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morscio J, Dierickx D, Ferreiro J, Herreman A, Van Loo P, Bittoun E, et al.
Am J Transplant
. 2013 Mar;
13(5):1305-16.
PMID: 23489474
Posttransplant patients are at risk of developing a potentially life-threatening posttransplantation lymphoproliferative disorder (PTLD), most often of diffuse large B cell lymphoma (DLBCL) morphology and associated with Epstein-Barr Virus (EBV)...
2.
Van Den Berghe E, De Wolf-Peeters C, Louwagie A, Thomas J, Wlodarska I, Dal Cin P, et al.
Leuk Lymphoma
. 2011 Jan;
5(2-3):193-9.
PMID: 21269081
Thirteen patients with B-non Hodgkin's lymphoma and abnormalities of the short arm of chromosome 1 were evaluated, to see if this cytogenetic anomaly was associated with a particular subgroup of...
3.
Hamoudi R, Appert A, Ye H, Ruskone-Fourmestraux A, Streubel B, Chott A, et al.
Leukemia
. 2010 Jun;
24(8):1487-97.
PMID: 20520640
Mucosa-associated lymphoid tissue (MALT) lymphoma is characterized by t(11;18)(q21;q21)/API2-MALT1, t(1;14)(p22;q32)/BCL10-IGH and t(14;18)(q32;q21)/IGH-MALT1, which commonly activate the nuclear factor (NF)-kappaB pathway. Gastric MALT lymphomas harboring such translocations usually do not respond...
4.
Sprangers B, Van Wijmeersch B, Luyckx A, Sagaert X, De Somer L, Rutgeerts O, et al.
Leukemia
. 2008 Nov;
23(2):340-9.
PMID: 18987665
The role of graft-versus-malignancy reactivity in the effects of allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusion (DLI) for myelodysplastic syndromes is as yet not well established. Clinical data...
5.
Pospisilova H, Baens M, Michaux L, Stul M, Van Hummelen P, Van Loo P, et al.
Leukemia
. 2007 May;
21(9):2079-83.
PMID: 17525729
No abstract available.
6.
Fevery S, Billiau A, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, et al.
Leukemia
. 2007 May;
21(7):1451-9.
PMID: 17508005
We studied the effect of CTLA-4 blockade on graft-versus-leukemia and graft-versus-host responses in a mouse model of minor histocompatibility-mismatched bone marrow transplantation. Early CTLA-4 blockade induced acute graft-versus-host disease. Delayed...
7.
Martin-Subero J, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, et al.
Leukemia
. 2007 May;
21(7):1532-44.
PMID: 17495977
The biologic and pathologic features of B-cell malignancies bearing a translocation t(14;19)(q32;q13) leading to a fusion of IGH and BCL3 are still poorly described. Herein we report the results of...
8.
Sagaert X, Sprangers B, De Wolf-Peeters C
Leukemia
. 2007 May;
21(7):1378-86.
PMID: 17495967
The repertoire of B cells secreting antibodies with unique antigen-binding specificities is produced at two stages: a primary B-cell repertoire is formed in the bone marrow through immunoglobulin gene rearrangements,...
9.
Sagaert X, De Wolf-Peeters C, Noels H, Baens M
Leukemia
. 2007 Jan;
21(3):389-96.
PMID: 17230229
Mucosa-associated lymphoid tissue (MALT) lymphoma is a heterogeneous form of a B-cell non-Hodgkin's lymphoma with extranodal location. The gastrointestinal tract is the most common site of disease, but involvement of...
10.
De Paepe P, De Wolf-Peeters C
Leukemia
. 2006 Oct;
21(1):37-43.
PMID: 17039226
Diffuse large B-cell lymphoma (DLBCL) as defined by the World Health Organization (WHO) classification is clinically, morphologically and genetically a heterogeneous group of malignant proliferations of large lymphoid B cells....